We are live on ! Find out more
NEO icon

NeoGenomics

287 hedge funds and large institutions have $2.04B invested in NeoGenomics in 2023 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 87 increasing their positions, 97 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

171% more call options, than puts

Call options by funds: $17.6M | Put options by funds: $6.48M

37% more capital invested

Capital invested by funds: $1.48B → $2.04B (+$555M)

20% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 35

4.32% more ownership

Funds ownership: 94.35%98.67% (+4.3%)

1% more funds holding

Funds holding: 283287 (+4)

10% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 97

Holders
287
Holders Change
+4
Holders Change %
+1.41%
% of All Funds
4.18%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
42
Increased
87
Reduced
97
Closed
35
Calls
$17.6M
Puts
$6.48M
Net Calls
+$11.1M
Net Calls Change
+$8.13M

NEO Hedge Fund Activity: Q4 2023 in Review

287 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2023, worth a combined $2.04B — up 37% from $1.48B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new NEO positions and 35 closed out — a net gain of 7 holders — while 87 added to existing stakes and 97 trimmed.

The largest buyer was American Century Companies, adding an estimated $32.1M. The largest seller was Janus Henderson Group, cutting an estimated $13.5M.

  • 287 institutional investors held NeoGenomics (NEO) as of Q4 2023, up from 283 in Q3 2023.
  • Funds reported $2.04B of NeoGenomics stock for Q4 2023, up 37% quarter-over-quarter.
  • 42 funds opened new NeoGenomics positions in Q4 2023 and 35 closed out, a net change of +7 holders.
  • The largest NeoGenomics buyer in Q4 2023 was American Century Companies, an estimated $32.1M added.
  • The largest NeoGenomics seller in Q4 2023 was Janus Henderson Group, an estimated $13.5M sold.

Based on aggregated 13F filings for Q4 2023.